[Diphosphonates in the treatment of osteoporosis and in the prevention of associated fractures]
- PMID: 7789073
[Diphosphonates in the treatment of osteoporosis and in the prevention of associated fractures]
Abstract
Diphosphonates are capable to increase vertebral bone mineral mass in postmenopausal osteoporosis. Because the risk of fractures is related to the reduction of bone mass, the positive effect of diphosphonates most probably produced a decrease in fracture rate. At present these drugs represent a rational option for the treatment of postmenopausal osteoporosis.
Similar articles
-
[Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].Rev Chir Orthop Reparatrice Appar Mot. 1998 Nov;84(8):743-51. Rev Chir Orthop Reparatrice Appar Mot. 1998. PMID: 10192126 Review. French.
-
Aging bone and osteoporosis: strategies for preventing fractures in the elderly.Arch Intern Med. 2003 Oct 13;163(18):2237-46. doi: 10.1001/archinte.163.18.2237. Arch Intern Med. 2003. PMID: 14557222 Review.
-
Prevention of postmenopausal bone loss and treatment of osteoporosis.Semin Reprod Med. 2005 May;23(2):141-8. doi: 10.1055/s-2005-869481. Semin Reprod Med. 2005. PMID: 15852199 Review.
-
Is bone mineral density predictive of fracture risk reduction?Curr Med Res Opin. 2004 Mar;20(3):341-9. doi: 10.1185/030079903125003062. Curr Med Res Opin. 2004. PMID: 15025843 Review.
-
Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review.J Reprod Med. 2003 Jun;48(6):425-34. J Reprod Med. 2003. PMID: 12856513 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical